Impact of time to treatment with tissue plasminogen activator on morbidity and mortality following acute myocardial infarction (the second National Registry of Myocardial Infarction)
- 1 August 1998
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 82 (3) , 259-264
- https://doi.org/10.1016/s0002-9149(98)00342-7
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Time from symptom onset to treatment and outcomes after thrombolytic therapyJournal of the American College of Cardiology, 1996
- Recent Trends in Acute Coronary Heart Disease — Mortality, Morbidity, Medical Care, and Risk FactorsNew England Journal of Medicine, 1996
- Stroke After ThrombolysisCirculation, 1995
- Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction.Circulation, 1994
- The Open-Artery Theory Is Alive and Well -- AgainNew England Journal of Medicine, 1993
- The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- A communitywide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease.Circulation, 1993
- Time delays in the diagnosis and treatment of acute myocardial infarction: A tale of eight cities Report from the Pre-hospital Study Group and the Cincinnati Heart ProjectAmerican Heart Journal, 1990
- Incidence and case fatality rates of acute myocardial infarction (1975–1984): The Worcester Heart Attack StudyAmerican Heart Journal, 1988